CIK 0001649094 · Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464233385
- Phone
- 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,185,988
- in 8 filings, $4.8M under 10b5-1 plans
Net −$5,185,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-01 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −185 | $63.65 | $12K | 215,462 |
| 2024-05-01 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −728 | $61.25 | $45K | 146,634 |
| 2024-05-01 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −508 | $62.01 | $31K | 146,126 |
| 2024-05-01 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −72 | $63.87 | $5K | 146,054 |
| 2024-05-01 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −680 | $61.28 | $42K | 146,682 |
| 2024-05-01 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −582 | $62.07 | $36K | 146,100 |
| 2024-05-01 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −46 | $63.84 | $3K | 146,054 |
| 2024-04-23 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Option exercise 10b5-1 | +15,000 | $1.79 | $27K | 492,847 |
| 2024-04-23 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −15,000 | $61.92 | $929K | 477,847 |
| 2024-04-23 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −15,000 | 225 | ||
| 2024-04-18 | GUGGENHIME ANDREW PRESIDENT AND CFO | Option exercise 10b5-1 | +8,000 | $5.35 | $43K | 103,679 |
| 2024-04-18 | GUGGENHIME ANDREW PRESIDENT AND CFO | Sale 10b5-1 | −7,624 | $61.24 | $467K | 96,055 |
| 2024-04-18 | GUGGENHIME ANDREW PRESIDENT AND CFO | Sale 10b5-1 | −376 | $61.90 | $23K | 95,679 |
| 2024-04-18 | GUGGENHIME ANDREW PRESIDENT AND CFO | Option exercise · Stock Option (right to buy) 10b5-1 | −8,000 | 360,827 | ||
| 2024-04-17 | Wassil Jim CHIEF OPERATING OFFICER | Option exercise | +3,551 | $5.35 | $19K | 221,840 |
| 2024-04-17 | Wassil Jim CHIEF OPERATING OFFICER | Option exercise · Stock Option (right to buy) | −3,551 | 78,611 | ||
| 2024-04-01 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Option exercise 10b5-1 | +1,667 | $21.41 | $36K | 32,264 |
| 2024-04-01 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −1,397 | $66.59 | $93K | 30,867 |
| 2024-04-01 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −270 | $67.42 | $18K | 30,597 |
| 2024-04-01 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Option exercise · Stock Option (right to buy) 10b5-1 | −1,667 | 188,332 |
Page 29 of 39 · 764 trades